From GlobeNewswire: 2024-04-30 07:30:00

The Digital Pathology Market is set to reach over USD 2.4 billion in revenue by 2032 due to the increasing prevalence of chronic diseases. Advanced imaging tools in digital pathology help pathologists analyze tissue samples more accurately, leading to better diagnoses and treatment decisions. Technological advancements like whole slide imaging and AI are driving innovations in the field for improved efficiency and diagnostic accuracy.

The teleconsultation application segment is expected to grow significantly from 2024 to 2032 in digital pathology, allowing pathologists to collaborate remotely in real-time for better diagnoses. Biotech & pharma companies are adopting digital pathology solutions to streamline drug discovery processes, leading to faster evaluations and decision-making. The Asia Pacific region is emerging as a lucrative market for digital pathology due to expanding healthcare infrastructure and rising healthcare expenditure.

Top firms in the digital pathology market include Roche, Danaher Corporation, and Philips, focusing on strategic partnerships and product launches for market expansion. In February 2024, Roche partnered with PathAI for AI-driven technology in pathology. The industry insights highlight the impact of COVID-19, technological landscape, regulatory framework, growth drivers, and challenges in the digital pathology market, offering valuable insights for stakeholders and decision-makers.



Read more at GlobeNewswire: Digital Pathology Market to hit USD 2.4 Bn by 2032, says